The production of tablet insulin has made new progress

Long-awaited tablet insulin may become a reality later this decade.

Two pharmaceutical companies, Novo Nordisk (Denmark) and Oramed Pharmaceuticals (Israel), are close to making this new tablet and insulin tablets are in the process of clinical trials.

Create insulin capsules to help patients drink instead of long injections that have been waiting for diabetics. Thanks to the crust, insulin is protected until it reaches the small intestine and is absorbed into the blood, not damaged by acid in the mouth, throat and stomach.

Injections of insulin cause pain and risk of infection.(Photo: ushairtransplant.com)

So far, injecting insulin into the body is thought to be painful and there is a risk of infection. Scientists from many countries around the world have actively studied this issue but have not achieved positive results.

Mr. Nadav Kidron, executive director of Oramed Pharmaceuticals, said the product also had to wait for approval from the US Food and Drug Administration (FDA) and this was a long, demanding process. test on a large scale.

Medicines for diabetics have been found since 1922 and so far no medicine has been able to replace insulin. The only difference is in how to use the medicine.

When a patient is forced to perform several injections a day or it can be said that they need to live with a needle in their hands, the method of giving the medicine to the body more conveniently can make the patient turn a blind eye to some impairments. defects of new pharmaceuticals.

Therefore, while diabetics criticize overly cautious regulators with tablet insulin drugs , experts agree with particularly rigorous regulations in preliminary tests. Because above all, "no harm" is still considered the most important principle in medicine.